Opportunities for Harold Hamm Diabetes Center members include funding awards
and access to
core facilities. Several types of funding awards are available to members to support the
development of their work. Award applications are evaluated on a competitive,
peer-reviewed basis by the Harold Hamm Research Grants Committee and External
Review Panel. Additional awards, such as matching awards to other funding
opportunities, will be announced if they become available.
Spring 2025 Award Opportunities
Funding Opportunity Summary
The Harold Hamm Diabetes Center (HHDC) is pleased to announce pilot funding
opportunities for 2025. The HHDC Pilot Program will consider funding seven
types of proposals including a new funding opportunity, the I2 Impact
& Innovation Award. In addition, HHDC will consider Team Science proposals,
Novel Pilot Projects, Novel Pilot Projects for Post-Docs, Bridge Funding,
Equipment Grants and Travel Reimbursement proposals. Based on a matching
gift, the HHDC will award up to $2.5M to researchers to launch investigations
for diabetes research. These funds will be augmented with a collaboration
with the Stephenson Cancer Center for projects that feature collaboration
between researchers in diabetes and cancer. These HHDC-SCC awards are
available for Team Science and Novel Pilot for Post-Docs projects.
Key Information
HHDC Funded Programs:
I2 Impact & Innovation Award: $300,000 for up to 2 years
Team Science Grant: $100,000 per year for up to 3 years
Novel Pilot Project Grant: $70,000 per year for up to 2 years
Novel Pilot Project Grant for Post-Docs: $70,000 per year for up to 2 years
Bridge Grant: $100,000 for 1 year
Equipment Grant: Up to $250,000
Travel Reimbursement: Up to $2,500. Note that these are now accepted on
a rolling basis, without a fixed due date.
HHDC-SCC Funded Programs:
Team Science Grant: $100,000 per year for up to 3 years
Novel Pilot Project Grant for Post-Docs: $70,000 per year for up to 2 years
Funding Priorities:
Applications should be closely aligned with the mission of the HHDC to
increase understanding about the causes and consequences of diabetes and
closely related cardiometabolic conditions like obesity, liver disease,
and cancer, as well as strategies for prevention or treatment of these
conditions. Additionally, proposals that address one or more of the following
themes are HHDC funding priorities:
Theme 1:
Diabetes and Obesity, origins within the first 1000 days of life or changes
across the lifespan. These are proposals that aim to gain basic science and clinical knowledge
on the inter-relationship of obesity and diabetes during fetal development
and early life, or across the lifespan. For example, we are interested
in studies of the genetic, epigenetic, and environmental basis of susceptibility
to developing insulin resistance, metabolic dysregulation, inflammation,
macrovascular and microvascular diabetic complications, obesity, and diabetes.
Theme 2: Translational Research. We encourage new collaborative projects between a Principal Investigator
(PI) who is a basic scientist and a PI who is a clinician or clinical
scientist. These projects must focus on patients or patient samples. At
least one of the two collaborating PIs must be from the College of Medicine.
If you are applying for this paired Basic/Clinical award, please specify
this within the Letter of Intent, and detail the roles of the collaborators.
Theme 3:
Clinical Research/Public Health. We seek proposals to investigate new treatments, interventions, and technology
for diabetes management, along with strategies to raise awareness, promote
prevention, or improve diabetes care. Proposals that address health disparities
related to diabetes, and early stage clinical investigators are particularly
encouraged.
The emphasis of the HHDC pilot program is to provide foundational support
that will permit investigators to compete successfully for extramural
sources of research support such as the NIH, American Diabetes Association,
JDRF, etc. Projects without evidence of potential for generating external
funding will be given lower priority scores during evaluation.
Eligibility
The PI of any HHDC grant application must be a Member of the HHDC; the
co-investigators do not have to be members at the time of application,
but if successful are encouraged to become Members or Associate Members
of the HHDC during the tenure of the grant. Recipients of
active HHDC grants may not apply for, or hold another HHDC grant or Team Science
grant as project PI or MPI. An exception to the latter rule is that current
grantees may apply for the new I2 Award described above.
Application Process
Letter of Intent
Letters of Intent are due to
HHDCGrants@ouhsc.edu by
5 p.m. on Friday, Jan. 10, 2025. Applicants with LOI proposals that fit the HHDC mission and have potential
for success will be invited to submit a full application in March. All
LOI applicants will be notified about the status of their proposal by
Jan. 31, 2025.
Please see the templates below for grant-specific submission requirements.
Full Application
Application attachments will vary by proposal type. Please see grant specific
instructions below for further information.
In accordance with OUHSC policy, a SoonerTrack routing form should be submitted
at least three to five full business days prior to the March 18, 2025 grant
application deadline. Applicants are expected to work with their assigned Sponsored Program
Administrator (SPA) for review of the application.
Once the review is complete, the Face Page of the application must be signed
by the ORA Official (or equivalent signing official at institutions other
than OUHSC) before the PI submits the final application to HHDC.
External Applicants will need to use their own institution’s offices for any grant processing,
and comply with the March 18, 2025 grant application deadline above.
Submission and Review of Final Application
Send the final application by e-mail to
HHDCGrants@ouhsc.edu no later than
5 p.m. on Tuesday,March 18, 2025. Please title the application attached to the email: HHDC <Type of Grant>
Grant-[PI Last Name, First Name].
Please submit the application as a single file in pdf format. Failure to follow these steps could cause your application to be overlooked
and not reviewed by the HHDC Grants Review Committee.
The HHDC Grants Review Committee will review and award grants in consultation
with two outside reviewers and one internal reviewer. Outside reviewers
will be selected for each application based on their relevant subject
matter expertise. Applicants are required to provide the names of
three potential outside reviewers in their LOI. The list should consist of people
who are able to provide an unbiased, objective assessment of the proposal;
however, reviewers should not be current or former mentors, collaborators,
or trainees of the PI or co-investigators. External reviewers should be
at institutions outside of Oklahoma but within the United States. Final
selection of the outside reviewers will be made by the HHDC Grants Review
Committee. Once appointed, the internal committee and panel of outside
reviewers will evaluate the proposal to come to a funding decision.
Program Application and Deadlines
All applications will follow the HHDC Application Form, Terms and Guidelines
found here:
Pediatric Diabetes & Endocrinology, Diabetes & EndocrinologyTulsa, OKView Profile
4.7 out of 5
.png)
